Description
A 39-amino acid research peptide studied for triple agonist activity at the GIP, GLP-1, and glucagon receptors, with research interest in metabolic regulation, energy balance, and body composition-
related pathways.
Compound Information
Technical specifications
Molecular Profile
What Is GLP-3 (RT)?
Synthetic peptide
2381089-83-2
4,731 g/mol
39
C20 diacid
Storage Requirements
Stability Information
Sources & References
Peer-reviewed research and scientific resources
New England Journal of Medicine
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A
Phase 2 Trial
The Lancet
Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for
People with Type 2 Diabetes
Nature Medicine
Triple Hormone Receptor Agonist Retatrutide for Metabolic
Dysfunction-Associated Steatotic Liver Disease
The Lancet Diabetes & Endocrinology
Effects of Retatrutide on Body Composition in People with Type 2
Diabetes
PubMed Central
Efficacy and Safety of Retatrutide for Obesity Treatment
PubMed Central
Retatrutide and Emerging Applications in Obesity
Pharmacotherapy
PubMed Central
Triple Agonism-Based Therapies for Obesity
Cell Discovery
Structural Insights into Triple Agonism at GLP-1R, GIPR and
GCGR Manifested by Retatrutide
PubChem Compound Database
Retatrutide Compound Record
Additional information
| Dosage | 10MG, 30MG |
|---|
Only logged in customers who have purchased this product may leave a review.
Related products
-
MOTS-C
$35.00Select options This product has multiple variants. The options may be chosen on the product page -
5-Amino-1MQ
$25.00Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.